| 前收市價 | 40.67 |
| 開市 | 36.86 |
| 買盤 | 32.90 |
| 賣出價 | 36.50 |
| 拍板 | 130.00 |
| 到期日 | 2025-12-19 |
| 今日波幅 | 36.86 - 40.67 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 1 |
ZacksPFE & BNTX Get Positive CHMP Opinion for Updated COVID-19 Jab
The Committee for Medicinal Products for Human Use recommends marketing authorization for Pfizer and BioNTech's updated version of mRNA COVID-19 jab, Comirnaty.
Barrons.comBioNTech Is More Than a Covid-19 Stock. It’s Having a Great September.
Recently BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry upside down.
Investor's Business DailyHow BioNTech, Up 26% Over Four Days, Is Riding Summit's Coattails To A Recovery
BioNTech stock has climbed 26% over four days as the German biotech rides a round of cancer treatment success from Summit Therapeutics.
